For healthcare professionals only


  





    


  


 


Alliimentum





*† 1


  in 1–4


Contains 2’-FL* which has proven benefi ts for the gut and systemic immune responses‡


 §  


 


7–9


 


IMPORTANT NOTICE: Breastfeeding is best for infants and is recommended for as long as possible during infancy. Alimentum is a food for special medical purposes and should only be used under the recommendation or guidance of a healthcare professional.


*The 2’-FL (2’-fucosyllactose) used in this formula is biosynthesised and structurally identical to the human milk oligosaccharide (HMO) 2’-FL, found in


most mothers’ breast milk.1 †MIMS. August 2020. ‡Studies conducted in healthy-term infants consuming standard Similac formula with 2’-FL (not Alimentum), compared to control formula without 2’-FL.


Parent reports from a single-arm study, where all infants were consuming an extensively hydrolysed formula before being switched to Alimentum with 2’-FL for 60 days. After 7 days of switching to Alimentum with 2’-FL, the majority of parents reported that the following persisting symptoms had improved or resolved: 84% of infants with constipation, 71% of infants with eczema, 100% of infants with vomiting.7


§Studies conducted in infants fed standard Alimentum formula without 2’-FL. ¶


References. 1. Reverri EJ, et al. Nutrients. 2018;10(10):1346. 2. Goehring KC, et al. J Nutr. 2016;146(12):2559–2566. 3. Marriage BJ, et al. J Pediatr Gastroenterol Nutr. 2015;61(6):649–658. 4. Triantis V, et al. Front Pediatr. 2018;2;6:190. 5. Borschel M. Allergy. 2014;69(Suppl. 99): 454–572. 6. Sampson HA, et al. J Pediatr. 1991;118(4 Pt 1):520–525. 7. Abbott. Data on File (AL32). April 2020. 8. Borschel MW, Baggs GE. T O Nutr J. 2015;9:1–4. 9. Abbott. UK Alimentum Market Research. 2018.


UK—2000071 August 2020


 





F


R O


W





OI C


R P


E S


W O


I 


E


&


AV K


ED





GR


Y


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48